Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Ann Surg Oncol. 2021 Feb 22;28(9):5121–5131. doi: 10.1245/s10434-021-09710-8

Table IIb:

Baseline Study Population Characteristics in Model Development and Validation

Breast Cancer Patients Cohorts Development Validation
n % n %
Admitting Primary Surgeon General Surgeon 147780 90.3 25600 89.6
Plastic Surgeon 15833 9.7 2984 10.4
Admission Quarter January 1 - March 31 41442 25.3 7499 26.2
April 1 - June 30 39059 23.9 6901 24.1
July 1 - September 30 41824 25.6 6639 23.2
October 1 - December 31 41288 25.2 7545 26.4
Surgery Type Partial Mastectomy 67922 41.5 13677 47.8
Oncoplastic Surgery 10162 6.2 1399 4.9
Mastectomy Alone 45690 20.7 7111 24.9
Mastectomy with Implant 33865 20.7 5602 19.6
Mastectomy with Muscular Flap 5974 3.7 795 2.0
Axillary Lymph Node Management None
SLNBx
61343
76128
37.5
46.5
11253
14288
39.3
50.0
ALNDx 26142 16.0 3063 10.7
Anesthesia Type General 153020 93.5 26750 93.6
Monitored Anesthesia Care 9569 5.8 1722 6.0
Other: Spinal, Local or Regional block 1024 0.6 112 0.4
Foreign Body Placement Yes 954 0.6 110 0.4
Any Complication Yes 8797 5.4 1217 4.3
Infectious Complication Yes 6239 3.8 927 3.2
Hematologic Complication Yes 2107 1.3 256 0.9
Internal Organ Complication Yes 639 0.4 81 0.3